XML 38 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
INVESTMENTS (Tables)
 9 Months Ended
Mar. 31, 2017
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Investments in Unconsolidated Affiliates
The Company's investments in unconsolidated affiliates consisted of the following (in thousands):
 
Carrying Value
 
Equity in Net Income (Loss)
 
 
 
 
Three Months Ended March 31,
Nine Months Ended March 31,
 
March 31, 2017
June 30, 2016
 
2017
2016
2017
2016
FFF Enterprises, Inc.
$
91,469

$
—

 
$
217

$
—

$
4,394

$
—

BloodSolutions, LLC
2,091

2,185

 
(42
)
—

(94
)
—

PharmaPoint, LLC
4,318

4,572

 
(92
)
(108
)
(254
)
(284
)
Innovatix, LLC
—

9,043

 
—

6,735

10,743

15,992

Other investments
1,000

1,000

 
—

—

—

294

Total investments
$
98,878

$
16,800

 
$
83

$
6,627

$
14,789

$
16,002
Schedule of Marketable Securities, Classified as Available-For-Sale
At June 30, 2016, marketable securities, classified as available-for-sale, consisted of the following (in thousands):
 
Amortized Cost
Gross Unrealized Gains
Gross Unrealized Losses
Fair Market Value
June 30, 2016
 
 
 
 
Corporate debt securities
$
33,267

$
—

$
(135
)
$
33,132

Asset-backed securities
14,755

3

(1
)
14,757

Total marketable securities
$
48,022

$
3

$
(136
)
$
47,889